Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jul 15;98(2):497–502. doi: 10.1172/JCI118817

Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.

C Fillat 1, C M Simonaro 1, P L Yeyati 1, J L Abkowitz 1, M E Haskins 1, E H Schuchman 1
PMCID: PMC507455  PMID: 8755662

Abstract

Mucopolysacchariodosis type VI (MPS VI) is the lysosomal storage disorder caused by the deficient activity of arylsulfatase B (ASB; N-acetylgalactosamine 4-sulfatase) and the subsequent accumulation of the glycosaminoglycan (GAG), dermatan sulfate. In this study, a retroviral vector containing the full-length human ASB cDNA was constructed and used to transduce skin fibroblasts, chondrocytes, and bone marrow cells from human patients, cats, or rats with MPS VI. The ASB vector expressed high levels of enzymatic activity in each of the cell types tested and, in the case of cat and rat cells, enzymatic expression led to complete normalization of 35SO4 incorporation. In contrast, overexpression of ASB in human MPS VI skin fibroblasts did not lead to metabolic correction. High-level ASB expression was detected for up to eight weeks in transduced MPS VI cat and rat bone marrow cultures, and PCR analysis demonstrated retroviral-mediated gene transfer to approximately 30-50% of the CFU GM-derived colonies. Notably, overexpression of ASB in bone marrow cells led to release of the enzyme into the media and uptake by MPS VI cat and rat skin fibroblasts and/or chondrocytes via the mannose-6-phosphate receptor system, leading to metabolic correction. Thus, these studies provide important rationale for the development of gene therapy for this disorder and lay the frame-work for future in vivo studies in the animal model systems.

Full Text

The Full Text of this article is available as a PDF (165.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anson D. S., Muller V., Bielicki J., Harper G. S., Hopwood J. J. Overexpression of N-acetylgalactosamine-4-sulphatase induces a multiple sulphatase deficiency in mucopolysaccharidosis-type-VI fibroblasts. Biochem J. 1993 Sep 15;294(Pt 3):657–662. doi: 10.1042/bj2940657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anson D. S., Taylor J. A., Bielicki J., Harper G. S., Peters C., Gibson G. J., Hopwood J. J. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J. 1992 Jun 15;284(Pt 3):789–794. doi: 10.1042/bj2840789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bienzle D., Abrams-Ogg A. C., Kruth S. A., Ackland-Snow J., Carter R. F., Dick J. E., Jacobs R. M., Kamel-Reid S., Dubé I. D. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):350–354. doi: 10.1073/pnas.91.1.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Birkenmeier E. H., Barker J. E., Vogler C. A., Kyle J. W., Sly W. S., Gwynn B., Levy B., Pegors C. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood. 1991 Dec 1;78(11):3081–3092. [PubMed] [Google Scholar]
  5. Bujía J., Kremer D., Sudhoff H., Viviente E., Sprekelsen C., Wilmes E. Determination of viability of cryopreserved cartilage grafts. Eur Arch Otorhinolaryngol. 1995;252(1):30–34. doi: 10.1007/BF00171437. [DOI] [PubMed] [Google Scholar]
  6. Horton R. M., Hunt H. D., Ho S. N., Pullen J. K., Pease L. R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989 Apr 15;77(1):61–68. doi: 10.1016/0378-1119(89)90359-4. [DOI] [PubMed] [Google Scholar]
  7. Isbrandt D., Arlt G., Brooks D. A., Hopwood J. J., von Figura K., Peters C. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet. 1994 Mar;54(3):454–463. [PMC free article] [PubMed] [Google Scholar]
  8. Jackson C. E., Yuhki N., Desnick R. J., Haskins M. E., O'Brien S. J., Schuchman E. H. Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1. Genomics. 1992 Oct;14(2):403–411. doi: 10.1016/s0888-7543(05)80233-2. [DOI] [PubMed] [Google Scholar]
  9. Jezyk P. F., Haskins M. E., Patterson D. F., Mellman W. J., Greenstein M. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Science. 1977 Nov 25;198(4319):834–836. doi: 10.1126/science.144321. [DOI] [PubMed] [Google Scholar]
  10. Jin W. D., Jackson C. E., Desnick R. J., Schuchman E. H. Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity. Am J Hum Genet. 1992 Apr;50(4):795–800. [PMC free article] [PubMed] [Google Scholar]
  11. Kunieda T., Simonaro C. M., Yoshida M., Ikadai H., Levan G., Desnick R. J., Schuchman E. H. Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation. Genomics. 1995 Oct 10;29(3):582–587. doi: 10.1006/geno.1995.9962. [DOI] [PubMed] [Google Scholar]
  12. Legros M., Fleury J., Curé H., Condat P., Lenat A., Subtil E., Sanderson D., Communal Y., Basile M., Tavernier F. New method for stem cell quantification: applications to the management of peripheral blood stem cell transplantation. Bone Marrow Transplant. 1995 Jan;15(1):1–8. [PubMed] [Google Scholar]
  13. Markowitz D., Goff S., Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 1988 Dec;167(2):400–406. [PubMed] [Google Scholar]
  14. McGovern M. M., Ludman M. D., Short M. P., Steinfeld L., Kattan M., Raab E. L., Krivit W., Desnick R. J. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT. Birth Defects Orig Artic Ser. 1986;22(1):41–53. [PubMed] [Google Scholar]
  15. McGovern M. M., Vine D. T., Haskins M. E., Desnick R. J. An improved method for heterozygote identification in feline and human mucopolysaccharidosis VI, arylsulfatase-B deficiency. Enzyme. 1981;26(4):206–210. doi: 10.1159/000459176. [DOI] [PubMed] [Google Scholar]
  16. Modaressi S., Rupp K., von Figura K., Peters C. Structure of the human arylsulfatase B gene. Biol Chem Hoppe Seyler. 1993 May;374(5):327–335. doi: 10.1515/bchm3.1993.374.1-6.327. [DOI] [PubMed] [Google Scholar]
  17. Peters C., Rommerskirch W., Modaressi S., von Figura K. Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer. Biochem J. 1991 Jun 1;276(Pt 2):499–504. doi: 10.1042/bj2760499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Peters C., Schmidt B., Rommerskirch W., Rupp K., Zühlsdorf M., Vingron M., Meyer H. E., Pohlmann R., von Figura K. Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J Biol Chem. 1990 Feb 25;265(6):3374–3381. [PubMed] [Google Scholar]
  19. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  20. Sands M. S., Barker J. E., Vogler C., Levy B., Gwynn B., Galvin N., Sly W. S., Birkenmeier E. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest. 1993 Jun;68(6):676–686. [PubMed] [Google Scholar]
  21. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schuchman E. H., Jackson C. E., Desnick R. J. Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and C. Genomics. 1990 Jan;6(1):149–158. doi: 10.1016/0888-7543(90)90460-c. [DOI] [PubMed] [Google Scholar]
  23. Tsukazaki T., Usa T., Matsumoto T., Enomoto H., Ohtsuru A., Namba H., Iwasaki K., Yamashita S. Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Exp Cell Res. 1994 Nov;215(1):9–16. doi: 10.1006/excr.1994.1307. [DOI] [PubMed] [Google Scholar]
  24. Yoshida M., Noguchi J., Ikadai H., Takahashi M., Nagase S. Arylsulfatase B-deficient mucopolysaccharidosis in rats. J Clin Invest. 1993 Mar;91(3):1099–1104. doi: 10.1172/JCI116268. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES